Arax Advisory Partners’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16	Closed	-$930	–	2591
2024 Q3	$930	Hold	16	–	–	﹤0.01%	2280
2024 Q2	$732	Buy	+16	New	+$732	﹤0.01%	2254